Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experiences with Prescribing Large Quantities of Systemic Anticancer Therapy Near Death.
Baena-Cañada JM, Campini Bermejo A, Gámez Casado S, Rodríguez Pérez L, Quílez Cutillas A, Calvete Candenas J, Martínez Bautista MJ, Benítez Rodríguez E. Baena-Cañada JM, et al. Among authors: rodriguez perez l. J Palliat Med. 2019 Dec;22(12):1515-1521. doi: 10.1089/jpm.2019.0017. Epub 2019 Jun 11. J Palliat Med. 2019. PMID: 31184989
Off-label antineoplastic drugs. An effectiveness and safety study.
Arroyo Álvarez C, Rodríguez Pérez L, Rodríguez Mateos ME, Martínez Bautista MJ, Benítez Rodríguez E, Baena-Cañada JM. Arroyo Álvarez C, et al. Among authors: rodriguez perez l, rodriguez mateos me. Farm Hosp. 2017 May 1;41(3):382-390. doi: 10.7399/fh.2017.41.3.10745. Farm Hosp. 2017. PMID: 28478752 English.
Evaluation of non-genomic, clinical risk and survival results in endocrine-sensitive, HER-2 negative, lymph node negative breast cancer.
Baena Cañada JM, Gámez Casado S, Rodríguez Pérez L, Quílez Cutillas A, Cortés Carmona C, Rosado Varela P, Estalella Mendoza S, Ramírez Daffós P, Benítez Rodríguez E. Baena Cañada JM, et al. Among authors: rodriguez perez l. Med Clin (Barc). 2018 Dec 21;151(12):469-475. doi: 10.1016/j.medcli.2018.01.020. Epub 2018 Feb 28. Med Clin (Barc). 2018. PMID: 29501438 English, Spanish.
Evaluation of waiting times for breast cancer diagnosis and surgical treatment.
Baena-Cañada JM, Rodríguez-Pérez L, Gámez-Casado S, Quílez-Cutillas A, Cortés-Carmona C, Rosado-Varela P, Estalella-Mendoza S, Ramírez-Daffós P, Jaén-Olasolo J, Benítez-Rodríguez E. Baena-Cañada JM, et al. Among authors: rodriguez perez l. Clin Transl Oncol. 2018 Oct;20(10):1345-1352. doi: 10.1007/s12094-018-1867-7. Epub 2018 Apr 9. Clin Transl Oncol. 2018. PMID: 29633184
Clinicopathological characteristics and survival results of patients with ultralow risk breast cancer.
Baena-Cañada JM, Gámez-Casado S, Rodríguez-Pérez L, Bandera-López C, Mesas-Ruiz A, Campini-Bermejo A, Bernal-Gómez M, Zalabardo-Aguilar M, Calvete-Candenas J, Martínez-Bernal G, Quílez-Cutillas A, Atienza-Cuevas L, García-Rojo M, Benítez-Rodríguez E, Pajares-Hachero B, Bermejo-Pérez MJ. Baena-Cañada JM, et al. Among authors: rodriguez perez l. Med Clin (Barc). 2022 Oct 28;159(8):351-358. doi: 10.1016/j.medcli.2021.11.008. Epub 2022 Feb 16. Med Clin (Barc). 2022. PMID: 35181168 English, Spanish.
Real world evidence of adjuvant trastuzumab in HER2 positive early breast cancer.
Lluch-Gómez J, Núñez-Álvarez V, de la Torre-Hita C, Bernal-Gómez M, Campini-Bermejo A, Perdomo-Zaldívar E, Rodríguez-Pérez L, Calvete-Candenas J, Martínez-Bautista MJ, Benítez-Rodríguez E, Baena-Cañada JM. Lluch-Gómez J, et al. Among authors: rodriguez perez l. Sci Rep. 2023 May 3;13(1):7168. doi: 10.1038/s41598-023-34429-9. Sci Rep. 2023. PMID: 37137963 Free PMC article.
Association between reproductive history, breast cancer subtype, and survival in premenopausal women.
Bernal-Gómez M, Núñez-Álvarez V, Lluch-Gómez J, de la Torre-Hita C, Campini-Bermejo A, Perdomo-Zaldívar E, Rodríguez-Pérez L, Calvete-Candenas J, Benítez-Rodríguez E, Baena-Cañada JM. Bernal-Gómez M, et al. Among authors: rodriguez perez l. Med Clin (Barc). 2024 Mar 22;162(6):265-272. doi: 10.1016/j.medcli.2023.10.015. Epub 2023 Nov 18. Med Clin (Barc). 2024. PMID: 37985328 English, Spanish.
Clinicopathological and Genomic Identification of Breast Cancers with No Impact on Mortality.
Gámez-Casado S, Rodríguez-Pérez L, Bandera-López C, Mesas-Ruiz A, Campini-Bermejo A, Bernal-Gómez M, Zalabardo-Aguilar M, Calvete-Candenas J, Martínez-Bernal G, Atienza-Cuevas L, García-Rojo M, Benítez-Rodríguez E, Pajares-Hachero B, Bermejo-Pérez MJ, Baena-Cañada JM. Gámez-Casado S, et al. Among authors: rodriguez perez l. Cancers (Basel). 2024 Mar 7;16(6):1086. doi: 10.3390/cancers16061086. Cancers (Basel). 2024. PMID: 38539421 Free PMC article.
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study.
Falcón González A, Cruz Jurado J, Llabrés Valenti E, Urbano Cubero R, Álamo de la Gala MC, Martínez Guisado MA, Álvarez Ambite R, Rodríguez González CJ, Amérigo Góngora M, Rodríguez Pérez L, López Álvarez P, Sánchez Rovira P, González Flores E, Henao Carrasco F, Bayo Calero J, Valero Arbizu M, Quílez Cutillas A, Salvador Boffil J, Rubio Pérez E, Ruiz-Borrego M. Falcón González A, et al. Among authors: rodriguez perez l. Clin Transl Oncol. 2024 Sep;26(9):2217-2226. doi: 10.1007/s12094-024-03440-5. Epub 2024 Mar 28. Clin Transl Oncol. 2024. PMID: 38538968 Free PMC article.
76 results